![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 1365-2265|81|3|329-333
ISSN: 0300-0664
Source: CLINICAL ENDOCRINOLOGY, Vol.81, Iss.3, 2014-09, pp. : 329-333
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Padberg B.-C. Rordorf T. Suter S. Pfeiffer D. Wild D. Schröder S.
Der Pathologe, Vol. 28, Iss. 4, 2007-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Upfront treatment of high‐risk neuroblastoma with a combination of 131I‐MIBG and Topotecan
PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. :